Cargando…

Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma

BACKGROUND: Estimation of the prognosis of resectable pancreatic ductal adenocarcinoma (PDAC) currently relies on tumour-related factors such as resection margins and on lymph-node ratio (LNR) both inconveniently available only postoperatively. Our aim was to assess the accuracy of preoperative labo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salmiheimo, Aino, Mustonen, Harri, Stenman, Ulf-Håkan, Puolakkainen, Pauli, Kemppainen, Esko, Seppänen, Hanna, Haglund, Caj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025052/ https://www.ncbi.nlm.nih.gov/pubmed/27632196 http://dx.doi.org/10.1371/journal.pone.0163064

Ejemplares similares

Pancreatic cancer survival prediction via inflammatory serum markers
por: Lanki, Mira, et al.
Publicado: (2022)

Combining CRP and CA19-9 in a novel prognostic score in pancreatic ductal adenocarcinoma
por: Nurmi, Anna M., et al.
Publicado: (2021)

Increasing the Inflammatory Competence of Macrophages with IL-6 or with Combination of IL-4 and LPS Restrains the Invasiveness of Pancreatic Cancer Cells
por: Salmiheimo, Aino N.E., et al.
Publicado: (2016)

Matrix Metalloproteinase 8 Expression in a Tumour Predicts a Favourable Prognosis in Pancreatic Ductal Adenocarcinoma
por: Kaasinen, Mirjami, et al.
Publicado: (2022)

Pancreatic fibrosis, acinar atrophy and chronic inflammation in surgical specimens associated with survival in patients with resectable pancreatic ductal adenocarcinoma
por: Korpela, Taija, et al.
Publicado: (2022)

Preoperative Biomarker Panel, Including Fibrinogen and FVIII, Improves Diagnostic Accuracy for Pancreatic Ductal Adenocarcinoma
por: Mattila, Nora, et al.
Publicado: (2018)

Preoperative oncologic therapy and the prolonged risk of venous thromboembolism in resectable pancreatic cancer
por: Eurola, Annika, et al.
Publicado: (2022)

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2015)

PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2016)

Toll-like receptor 1 predicts favorable prognosis in pancreatic cancer
por: Lanki, Mira, et al.
Publicado: (2019)

The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy
por: Nurmi, Anna Maria, et al.
Publicado: (2022)

Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis
por: Saraswat, Mayank, et al.
Publicado: (2017)

MAPK inhibitors induce serine peptidase inhibitor Kazal type 1 (SPINK1) secretion in BRAF V600E‐mutant colorectal adenocarcinoma
por: Räsänen, Kati, et al.
Publicado: (2017)

MRI follow-up for pancreatic intraductal papillary mucinous neoplasm: an ultrashort versus long protocol
por: Johansson, Katarina, et al.
Publicado: (2021)

Use of self-expandable metallic stents for endoscopic biliary decompression decreases stent complications in pancreatic cancer patients receiving chemotherapy
por: Vehviläinen, Sini, et al.
Publicado: (2021)

Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer
por: Böckelman, Camilla, et al.
Publicado: (2018)

Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer
por: Eurola, Annika, et al.
Publicado: (2021)

The possible dual role of Ang-2 in the prognosis of pancreatic cancer
por: Roos-Mattila, Matilda, et al.
Publicado: (2023)

Acute pancreatitis with organ dysfunction associates with abnormal blood lymphocyte signaling: controlled laboratory study
por: Oiva, Jani, et al.
Publicado: (2010)

Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring
por: Mäkinen, Lotta, et al.
Publicado: (2022)

Concomitant Tumor Expression of EGFR and TATI/SPINK1 Associates with Better Prognosis in Colorectal Cancer
por: Koskensalo, Selja, et al.
Publicado: (2013)

N-glycosylation in non-invasive and invasive intraductal papillary mucinous neoplasm
por: Nieminen, Heini, et al.
Publicado: (2023)

Impact of pasireotide on postoperative pancreatic fistulas following distal resections
por: Vuorela, Tiina, et al.
Publicado: (2021)

Elevated tumor expression of Astroprincin (FAM171A1) is an independent marker of poor prognosis in colon cancer
por: Kaprio, Tuomas, et al.
Publicado: (2021)

Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas
por: Heby, Margareta, et al.
Publicado: (2020)

Performance of Finnish biobanks in nationwide pulmonary carcinoid tumour research
por: Vesterinen, Tiina, et al.
Publicado: (2019)

REG4 Independently Predicts Better Prognosis in Non-Mucinous Colorectal Cancer
por: Kaprio, Tuomas, et al.
Publicado: (2014)

The prognostic role of tissue TLR2 and TLR4 in colorectal cancer
por: Beilmann-Lehtonen, Ines, et al.
Publicado: (2020)

Stage I–IV Colorectal Cancer Prognosis Can Be Predicted by Type and Number of Intratumoral Macrophages and CLEVER-1(+) Vessel Density
por: Ålgars, Annika, et al.
Publicado: (2021)

Combined epithelial marker analysis of tumour budding in stage II colorectal cancer
por: Slik, Khadija, et al.
Publicado: (2018)

Health-related quality of life and anxiety levels among patients under surveillance for intraductal papillary mucinous neoplasm
por: Nieminen, Heini, et al.
Publicado: (2023)

Blood Leukocyte Signaling Pathways as Predictors of Severity of Acute Pancreatitis
por: Turunen, Antti, et al.
Publicado: (2021)

A comparative study of two PODXL antibodies in 840 colorectal cancer patients
por: Kaprio, Tuomas, et al.
Publicado: (2014)

Podocalyxin is a marker of poor prognosis in colorectal cancer
por: Kaprio, Tuomas, et al.
Publicado: (2014)

High serum MMP-14 predicts worse survival in gastric cancer
por: Kasurinen, Aaro, et al.
Publicado: (2018)

Tumor-Associated Trypsin Inhibitor (TATI) as a Biomarker of Poor Prognosis in Oropharyngeal Squamous Cell Carcinoma Irrespective of HPV Status
por: Sjöblom, Anni, et al.
Publicado: (2021)

The Role of Human Chorionic Gonadotropin Beta (hCGβ) in HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma
por: Sjöblom, Anni, et al.
Publicado: (2022)

Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancer
por: Kaprio, Tuomas, et al.
Publicado: (2019)

Association between local immune cell infiltration, mismatch repair status and systemic inflammatory response in colorectal cancer
por: Gunnarsson, Ulf, et al.
Publicado: (2020)

The Prognostic Importance of CD20(+) B lymphocytes in Colorectal Cancer and the Relation to Other Immune Cell subsets
por: Edin, Sofia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e28aj77m254k4vvka9cekjkmcl